Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

PATENTS

Relieving patent-eligibility barriers in biotech with a preparation or treatment method

Nature Biotechnology volume 40, pages 651–653 (2022)Cite this article

Subjects

An analysis of decisions related to patent eligibility by the US Court of Appeals for the Federal Circuit indicates a way to avoid rejection or invalidation of eligibility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chang, B. C. & Wang, S.-J. Hum. Vaccin. Immunother. 11, 789–794 (2015).

    Article  Google Scholar 

  2. Aboy, M., Liddicoat, J., Liddell, K., Jordan, M. & Crespo, C. Nat. Biotechnol. 35, 820–825 (2017).

    Article  CAS  Google Scholar 

  3. Aboy, M., Crespo, C., Liddell, K., Minssen, T. & Liddicoat, J. Nat. Biotechnol. 37, 513–518 (2019).

    Article  CAS  Google Scholar 

  4. Wang, S. J. Hum. Vaccin. Immunother. 15, 2706–2712 (2019).

    Article  Google Scholar 

  5. Brougher, J. & Linnik, K. M. Nat. Biotechnol. 32, 877–880 (2014).

    Article  CAS  Google Scholar 

  6. Aboy, M. et al. Nat. Biotechnol. 37, 1118–1125 (2019).

    Article  CAS  Google Scholar 

  7. CosmoKey Solutions GmbH & Co. v. Duo Security LLC., 20–2043 (Fed. Cir. 4 October, 2021).

  8. Alice Corp. v. CLS Bank Int’l., 573 U.S. 208 (2014).

  9. Boehringer Ingelheim v. Mylan Pharmaceuticals Inc., 19–1172 (Fed. Cir. March 2020).

  10. Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Ltd., 16–2707 (Fed. Cir. April, 2018).

  11. US Patent and Trademark Office. Appendix 1 to the October 2019 Update: Subject Matter Eligibility Life Sciences & Data Processing Examples (2019); https://www.uspto.gov/sites/default/files/documents/peg_oct_2019_app1.pdf

  12. Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012).

  13. Illumina, Inc. v. Ariosa Diagnostics, Inc., 19–1419 (Fed. Cir. 17 March 2020).

  14. Hahn, S., Zhong, X. Y. & Holzgreve, W. Semin. Fetal Neonatal Med. 13, 57–62 (2008).

    Article  Google Scholar 

  15. Ariosa Diagnostics, Inc v. Sequenom, Inc., 788 F.3d 1371 (Fed. Cir. 2015).

  16. Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 576 (2013).

Download references

Acknowledgements

This work is supported in part by Ministry of Science and Technology (MOST 107-2410-H-075-001) and Taipei Veterans General Hospital (V108C-180, V110C-047 and V109D53-003-MY2-1), Taiwan.

Author information

Authors and Affiliations

  1. Department of Orthopaedics, Taipei Veterans General Hospital, Taipei, Taiwan

    Jir-You Wang

  2. Institute of Traditional Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Jir-You Wang

  3. Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan

    Yi-Fang Tsai, Tien-Hsiang Wang & Shyh-Jen Wang

  4. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Yi-Fang Tsai & Tien-Hsiang Wang

  5. Department of Mechanical Engineering, National Central University, Taoyuan, Taiwan

    Tien-Hsiang Wang

  6. Rehabilitation and Technical Aids Center, Taipei Veterans General Hospital, Taipei, Taiwan

    Shyh-Jen Wang

  7. Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Shyh-Jen Wang

Authors
  1. Jir-You Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi-Fang Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tien-Hsiang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shyh-Jen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shyh-Jen Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, JY., Tsai, YF., Wang, TH. et al. Relieving patent-eligibility barriers in biotech with a preparation or treatment method. Nat Biotechnol 40, 651–653 (2022). https://doi.org/10.1038/s41587-022-01301-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01301-6

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing